Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Feirui Biological Pharmaceutical is a specialized pharmaceutical enterprise based in China, focusing on the research, development, and manufacturing of steroid hormone APIs and intermediates. The company operates a large-scale production base in Hubei Province, utilizing advanced chemical synthesis and fermentation technologies to produce high-purity corticosteroids and progestogens. Their products are widely used in the formulation of anti-inflammatory, immunosuppressive, and hormonal therapies. Feirui serves as a key supplier in the global pharmaceutical supply chain, maintaining compliance with international quality standards to support both domestic and export markets. The company emphasizes technological innovation in steroid synthesis to improve yield and environmental sustainability. Their portfolio includes essential medicines such as dexamethasone and betamethasone, which are critical for treating a variety of systemic and local conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 湖北菲瑞生物药业.